Drug name - Oforta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7148207 SANOFI AVENTIS US Oral fludara of high-purity formulation with quick release of active ingredient Dec, 2022

(2 months from now)

Drugs and Companies using FLUDARABINE PHOSPHATE ingredient

Treatment: Treatment of patients with b-cell chronic lymphocytic leukemia (cll)


More Information on Dosage
Strength Dosage Availability
10MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.